These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 23702329)

  • 1. Protein glycation during aging and in cardiovascular disease.
    Simm A
    J Proteomics; 2013 Oct; 92():248-59. PubMed ID: 23702329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein glycation - Between tissue aging and protection.
    Simm A; Müller B; Nass N; Hofmann B; Bushnaq H; Silber RE; Bartling B
    Exp Gerontol; 2015 Aug; 68():71-5. PubMed ID: 25536383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of tissue accumulation levels of advanced glycation end products by skin autofluorescence: A novel marker of vascular complications in high-risk patients for cardiovascular disease.
    Yamagishi S; Fukami K; Matsui T
    Int J Cardiol; 2015 Apr; 185():263-8. PubMed ID: 25814214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aging induces cardiac diastolic dysfunction, oxidative stress, accumulation of advanced glycation endproducts and protein modification.
    Li SY; Du M; Dolence EK; Fang CX; Mayer GE; Ceylan-Isik AF; LaCour KH; Yang X; Wilbert CJ; Sreejayan N; Ren J
    Aging Cell; 2005 Apr; 4(2):57-64. PubMed ID: 15771609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond.
    Yan SF; Ramasamy R; Naka Y; Schmidt AM
    Circ Res; 2003 Dec; 93(12):1159-69. PubMed ID: 14670831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes.
    Yamagishi S
    Exp Gerontol; 2011 Apr; 46(4):217-24. PubMed ID: 21111800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biochemical properties and clinical significance of protein glycation products].
    Staniszewska M; Gamian A
    Postepy Hig Med Dosw; 2003; 57(2):123-47. PubMed ID: 12866352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathologic role of dietary advanced glycation end products in cardiometabolic disorders, and therapeutic intervention.
    Yamagishi S; Matsui T
    Nutrition; 2016 Feb; 32(2):157-65. PubMed ID: 26602289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of an aging-related increase in advanced glycation end products in fast- and slow-twitch skeletal muscles in the rat.
    Ramamurthy B; Larsson L
    Biogerontology; 2013 Jun; 14(3):293-301. PubMed ID: 23681254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor for Advanced Glycation Endproducts (RAGE): a formidable force in the pathogenesis of the cardiovascular complications of diabetes & aging.
    Yan SF; D'Agati V; Schmidt AM; Ramasamy R
    Curr Mol Med; 2007 Dec; 7(8):699-710. PubMed ID: 18331228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycation: the angiogenic paradox in aging and age-related disorders and diseases.
    Roca F; Grossin N; Chassagne P; Puisieux F; Boulanger E
    Ageing Res Rev; 2014 May; 15():146-60. PubMed ID: 24742501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced glycation end-product cross-link breakers. A novel approach to cardiovascular pathologies related to the aging process.
    Bakris GL; Bank AJ; Kass DA; Neutel JM; Preston RA; Oparil S
    Am J Hypertens; 2004 Dec; 17(12 Pt 2):23S-30S. PubMed ID: 15607432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular effects of advanced glycation end products on cell signalling pathways, ageing and pathophysiology.
    Nedić O; Rattan SI; Grune T; Trougakos IP
    Free Radic Res; 2013 Aug; 47 Suppl 1():28-38. PubMed ID: 23692178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of inflammation on the aging microcirculation: impact on skeletal muscle blood flow control.
    Payne GW
    Microcirculation; 2006 Jun; 13(4):343-52. PubMed ID: 16611596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced glycation end-products: a common pathway in diabetes and age-related erectile dysfunction.
    Neves D
    Free Radic Res; 2013 Aug; 47 Suppl 1():49-69. PubMed ID: 23822116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accumulation of advanced glycation end products and chronic complications in ESRD treated by dialysis.
    Meerwaldt R; Zeebregts CJ; Navis G; Hillebrands JL; Lefrandt JD; Smit AJ
    Am J Kidney Dis; 2009 Jan; 53(1):138-50. PubMed ID: 19036487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced glycation end-products (AGEs): involvement in aging and in neurodegenerative diseases.
    Grillo MA; Colombatto S
    Amino Acids; 2008 Jun; 35(1):29-36. PubMed ID: 18008028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glycation and protein crosslinking in the diabetes and ageing pathogenesis].
    Cárdenas-León M; Díaz-Díaz E; Argüelles-Medina R; Sánchez-Canales P; Díaz-Sánchez V; Larrea F
    Rev Invest Clin; 2009; 61(6):505-20. PubMed ID: 20184132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kidney, heart and brain: three organs targeted by ageing and glycation.
    Frimat M; Daroux M; Litke R; Nevière R; Tessier FJ; Boulanger E
    Clin Sci (Lond); 2017 Jun; 131(11):1069-1092. PubMed ID: 28515343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of maillard protein modifications in human lenses: effect of age and cataract.
    Smuda M; Henning C; Raghavan CT; Johar K; Vasavada AR; Nagaraj RH; Glomb MA
    Biochemistry; 2015 Apr; 54(15):2500-7. PubMed ID: 25849437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.